Related Experiment Video
Updated: May 28, 2026

Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
Published on: March 12, 2018
Copper Coordination to the Prion Fragment (95-126): Implications for Neurodegenerative Diseases
Chiara Bacchella1, Angelo Ferraresi1, Enrico Monzani1
1Dipartimento di Chimica, Università di Pavia, Via Taramelli 12, 27100 Pavia, Italy.
Abstract:
The causative event in transmissible spongiform encephalopathies is the misfolding of the prion protein (PrP), a process influenced, in a way that is not yet fully understood, by transition metal ions, particularly copper, which modulate folding, aggregation, and redox activity. In this study, we investigated the interaction of copper(II) ions with the prion fragment PrP(95-126), which includes the non-octarepeat high-affinity sites His96 and His111, as well as an amyloidogenic tail involved in PrP misfolding and membrane interaction. UV-vis and circular dichroism analyses revealed the predominant formation of a 1:1 Cu/PrP(95-126) complex, accompanied by modest restructuring, consistent with an increased aggregation propensity upon copper binding. The Cu/PrP(95-126) complexes exhibited limited redox activity toward catechol substrates, which was further reduced in membrane-mimetic systems such as SDS micelles and large unilamellar vesicles (LUVs). His96 appears not to play a critical role in copper coordination or redox activation. This study explores the coordination modes and reactivity of copper(II) with PrP, as well as employing a membrane mimic, aspects that are still highly controversial in the literature, providing insights for further in vitro studies.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology

